MPO and coronary artery disorder: The MPO concentrations in plasma of CAD patients were higher than in N subjects (SA, 38%, p = 0.0009; ACS, 96%, p = 3.9 × 10−5), and in ACS versus SA plasma (41%, p = 0.042) (Fig. 1c).